Ambev's Q3 Profit Jumps 8.7% Y/Y, Shares Gain On Higher Margins And Buyback

Benzinga
2025/10/31

Ambev SA (NYSE:ABEV) shares traded higher on Thursday after the company reported third-quarter FY25 results.

Details

Ambev reported quarterly earnings of 24 cents per share in Brazilian Reals (4 cents per share in USD), up 8.7% year over year (Y/Y), driven by lower taxes.

The company reported quarterly sales of 20.8 billion Brazilian Real ($3.826 billion), which declined 5.7% Y/Y.

Also Read: US Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn

Normalized EBITDA, meanwhile, increased by 2.9% Y/Y organically, and margins expanded 50 basis points, led by disciplined cost and expense management and efficient resource allocation.

Segment Performance

Net revenue per hectoliter (NR/hl) grew by 7.4%, contributing to overall net revenue increases in most business units: Brazil non-alcoholic beverages (NAB) rose by 0.5%, Caribbean (CAC) by 2.2% and Latin America South (LAS) by 9.2%, while Canada and Brazil Beer saw a decline of 0.1% and 2.1%, respectively, due to volume decreases.

Organically, volumes declined 5.8% Y/Y mainly due to unseasonable weather and a challenging environment in key markets. By Segment, volumes fell in Brazil Beer (-7.7% Y/Y), Brazil NAB (-8.6% Y/Y), Canada (-2.0% Y/Y), and LAS (-0.8% Y/Y).

Other Key Metrics

The Board of Directors approved a share repurchase program of up to 208 million shares, valued at about 2.5 billion Brazilian Reals based on the October 29, 2025, closing price, to be executed over the next 18 months.

As of September 30, cash and cash equivalents (less bank overdrafts) stood at 18.31 billion Brazilian Real.

Price Action: ABEV shares are up 5.28% at $2.295 at the last check on Thursday.

Read Next:

  • Latin America’s Hot Stocks: 3 NYSE Picks To Dodge Trade Wars, Mideast Mayhem

Photo: Shutterstock

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10